Keyphrases
Active Rheumatoid Arthritis
5%
Adaptive Immune Response
6%
Adipose Tissue
5%
Adipose-derived Stromal Cells
6%
Angiogenic Potential
5%
Antenatal Diagnosis
5%
Antiangiogenic Activity
5%
Antibiotics
5%
Anticardiolipin Antibodies
5%
Arthritis
5%
Atypical Symptoms
5%
Autoimmune Disease
13%
Bacterial DNA
5%
Bone Marrow Mononuclear Cells
6%
Bromocriptine
7%
Cardiopathy
5%
Cardiovascular Disease
6%
CD4+CD25+Foxp3+
5%
CD8+ T Cells
7%
Cell Dose
5%
Cell Therapy
16%
Cell-based
8%
Cellular Immune Response
7%
Chorion
5%
Chronic Kidney Disease
16%
Clinical Diagnosis
7%
Combination Therapy
5%
Connective Tissue Disease
5%
COVID-19
5%
Differentiation Potential
7%
Disease Activity
9%
Endometrial Stem Cells
18%
Etiology
7%
Experimental Autoimmune Encephalomyelitis
17%
Functional Damage
5%
Graft-versus-host Disease (GvHD)
7%
Group A Streptococcus
8%
Heart Failure Patients
13%
Human Mesenchymal Stem Cells (hMSCs)
20%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
5%
Human Umbilical Cord Mesenchymal Stromal Cells
11%
IL-17RA
5%
Immunomodulatory Effect
5%
Immunomodulatory Properties
5%
Immunosuppression
7%
Immunosuppressive Potential
5%
Immunosuppressive Properties
8%
Infarcted
5%
Inflammatory Response
7%
Innate Immune Response
6%
Interleukin-17 (IL-17)
17%
Interleukin-2
6%
Intravenous Infusion
8%
Joint Tenderness
5%
Knee Osteoarthritis
5%
Latin American
6%
Left Ventricle
5%
Lupus
5%
Mesenchymal Stem Cell Therapy
11%
Mesenchymal Stem Cells
97%
Mesenchymal Stromal Cells
14%
MicroRNA
6%
MicroRNA Profiling
5%
Myocardial Infarction
7%
Organ Damage
7%
Patients with Heart Failure
7%
Peripheral Blood Mononuclear Cells
6%
Perspectiva
5%
Phase II Trial
9%
Polymorphism
5%
Randomized Clinical Trial
7%
Randomized Controlled Trial
5%
Rat Model
16%
Regenerative Properties
6%
Regulatory T Cells
5%
Rheumatic Fever
16%
Rheumatic Heart Disease
16%
Rheumatoid Arthritis
7%
Secreted Factors
7%
Signaling Axis
5%
Stem Cell Delivery
6%
Stem Cell Support
5%
Stem Cell Therapy
13%
Stem Cell-derived
7%
Stem Cells
11%
Superantigen
6%
Systemic Lupus Erythematosus
32%
Systemic Lupus Erythematosus Patient
12%
T Cells
25%
T Helper 17 (Th17)
32%
Th1 Cells
14%
Therapeutic Effect
6%
Therapeutic Efficacy
5%
Tissue Damage
10%
Toll-like
11%
Transplantation
7%
Transplantation Tolerance
5%
Treg Differentiation
6%
Treg Lymphocytes
6%
Valvular
12%
Immunology and Microbiology
Adaptive Immune System
5%
Adipose Tissue
5%
Antimicrobial Agent
5%
Arthritis
11%
Autoimmune Disease
14%
Bone Marrow Derived Mesenchymal Stem Cell
13%
CD4
6%
Chorion
5%
Colitis
5%
Conditioning
5%
Connective Tissue
5%
Cytokine
6%
Dendritic Cell
5%
Eosinophilic Fasciitis
5%
Experimental Autoimmune Encephalomyelitis
19%
Graft-Versus-Host Disease
7%
Hematopoietic Cell
5%
Immunity
11%
Immunosuppressive Drug
24%
Inflammation Response
8%
Inflammatory Arthritis
6%
Innate Immune System
5%
Interleukin 6
8%
Lupus Erythematosus
7%
Mesenchymal Stem Cell
100%
Mitochondrion
5%
Rat Model
16%
Regulatory T Cell
11%
Rheumatic Heart Disease
5%
Stem Cell
16%
Stem Cell Transplantation
6%
Systemic Lupus Erythematosus
33%
T Cell
19%
T Cell Activation
7%
T-Helper Cell
8%
Th1 Cell
9%
Th17 Cell
16%
TLR3
6%
Tolerance in Transplantation
5%
Toll-Like Receptor
6%
Umbilical Cord
5%
Medicine and Dentistry
Adipose Tissue
5%
Adrenal Insufficiency
5%
Aldosterone
5%
Antiphospholipid Syndrome
5%
Autoimmune Disease
7%
Biological Marker
5%
Bone Marrow Cell
5%
Bone Marrow Derived Mesenchymal Stem Cell
7%
Cardiolipin Antibody
5%
Cardiovascular Disease
7%
Carditis
6%
Cell Therapy
13%
Chorion
5%
Chronic Kidney Disease
5%
Combination Therapy
5%
Congestive Heart Failure
8%
COVID-19
5%
Dilated Cardiomyopathy
5%
Disease
12%
Eosinophilic Fasciitis
5%
Experimental Autoimmune Encephalomyelitis
6%
Heart Disease
5%
Hematopoietic Cell
5%
Immunity
5%
Immunosuppressive Drug
7%
Infection
12%
Intravenous Drug Administration
6%
Knee Osteoarthritis
5%
Lupus Erythematosus
5%
Mesenchymal Stem Cell
43%
microRNA
6%
Mononuclear Cell
5%
Quality of Life
7%
Randomized Clinical Trial
7%
Randomized Controlled Trial
5%
Receptor
5%
Restylane
5%
Rheumatic Fever
10%
Rheumatic Heart Disease
5%
Stem Cell
15%
Stem Cell Therapy
7%
Stromal Cell
5%
Systemic Lupus Erythematosus
28%
T Cell
10%
Th17 Cell
6%
Umbilical Cord
11%
Virus Infection
5%